AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 8853523 — intervention group
Group type: EXPERIMENTAL
Intervention: New anti-cancer agents in phase IV studies
Number of subjects: 0
Study 2277378 — intervention group
Group type: EXPERIMENTAL
Intervention: cefmetazole
Number of subjects: 145
Study 2277378 — intervention group
Group type: COMPARATOR
Intervention: cefoxitin
Number of subjects: 145
Study 6990475 — intervention group
Group type: EXPERIMENTAL
Intervention: 14-valent pneumococcal capsular polysaccharide vaccine (Pn)
Number of subjects: 313
Study 6990475 — intervention group
Group type: COMPARATOR
Intervention: Haemophilus influenzae type b capsular polysaccharide vaccine (Hib)
Number of subjects: 313
Study 6990475 — intervention group
Group type: EXPERIMENTAL
Intervention: Both vaccines
Number of subjects: 313
Study 29562806 — intervention group
Group type: EXPERIMENTAL
Intervention: Calcitriol therapy
Number of subjects: 18
Study 29562806 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 27355577 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transorbital alternating current stimulation (rtACS) for 50 min daily for 10 days
Number of subjects: 82
Study 27355577 — intervention group
Group type: COMPARATOR
Intervention: Sham-stimulation for 50 min daily for 10 days
Number of subjects: 82
Study 27355577 — intervention group
Group type: EXPERIMENTAL
Intervention: Repetitive transorbital alternating current stimulation (rtACS)
Number of subjects: 82
Study 24374518 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-gripping Progrip mesh
Number of subjects: 1353
Study 24374518 — intervention group
Group type: COMPARATOR
Intervention: Conventional suture-fixed Lichtenstein technique
Number of subjects: 1353
Study 22349778 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based email messages (low frequency)
Number of subjects: 194
Study 22349778 — intervention group
Group type: EXPERIMENTAL
Intervention: TPB-based email messages (high frequency)
Number of subjects: 194
Study 20395940 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 1 minute
Number of subjects: 28
Study 20395940 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 2 minutes
Number of subjects: 28
Study 20395940 — intervention group
Group type: EXPERIMENTAL
Intervention: L-NMMA infusion after ischemia at wrist level for 5 minutes
Number of subjects: 28
Study 20395940 — intervention group
Group type: COMPARATOR
Intervention: Saline infusion after ischemia at upper arm
Number of subjects: 28
Study 19099330 — intervention group
Group type: COMPARATOR
Intervention: Normoxic condition (20.93% O2)
Number of subjects: 12
Study 19099330 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic condition (14% O2)
Number of subjects: 12
Study 19099330 — intervention group
Group type: EXPERIMENTAL
Intervention: Hypoxic condition (12% O2)
Number of subjects: 12
Study 16337144 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment
Number of subjects: 101
Study 16337144 — intervention group
Group type: COMPARATOR
Intervention: Medical treatment
Number of subjects: 101
Study 12681862 — intervention group
Group type: EXPERIMENTAL
Intervention: Ultrasound scan at 30-32 weeks' and 36-37 weeks' gestation
Number of subjects: 1998
Study 12681862 — intervention group
Group type: COMPARATOR
Intervention: Control group receiving standard antenatal care
Number of subjects: 1998
Study 10408999 — intervention group
Group type: EXPERIMENTAL
Intervention: Awareness group (received specific informational brochures on diet and cardiovascular risk factors and the reasons for the treatment)
Number of subjects: 3845
Study 10408999 — intervention group
Group type: COMPARATOR
Intervention: Control group (received the information normally given by the practitioners)
Number of subjects: 3845
Study 10408999 — intervention group
Group type: EXPERIMENTAL
Intervention: Noncompliant patients
Number of subjects: 3845
Study 8726532 — intervention group
Group type: EXPERIMENTAL
Intervention: Noun-related maps
Number of subjects: 0
Study 8726532 — intervention group
Group type: COMPARATOR
Intervention: Verb-related maps
Number of subjects: 0
Study 1932649 — intervention group
Group type: EXPERIMENTAL
Intervention: Bovine lung heparin (BLH)
Number of subjects: 40
Study 1932649 — intervention group
Group type: EXPERIMENTAL
Intervention: Porcine mucosal heparin (PMH)
Number of subjects: 40
Study 1932649 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 40
Study 7333749 — intervention group
Group type: COMPARATOR
Intervention: High blood glucose (G)
Number of subjects: 9
Study 7333749 — intervention group
Group type: COMPARATOR
Intervention: Control (C)
Number of subjects: 9
Study 7333749 — intervention group
Group type: EXPERIMENTAL
Intervention: High blood free fatty acid (F)
Number of subjects: 9
Study 31093835 — intervention group
Group type: EXPERIMENTAL
Intervention: Nurse-led telephone follow-up
Number of subjects: 0
Study 31093835 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-initiated follow-up
Number of subjects: 0
Study 31093835 — intervention group
Group type: COMPARATOR
Intervention: Routine hospital-based follow-up
Number of subjects: 0
Study 31093835 — intervention group
Group type: COMPARATOR
Intervention: Routine follow-up
Number of subjects: 0
Study 31093835 — intervention group
Group type: COMPARATOR
Intervention: Hospital-based follow-up
Number of subjects: 0
Study 28279705 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study 24947656 — intervention group
Group type: EXPERIMENTAL
Intervention: Normal colposcopy examination with follow-up cervical cytology every 6 months for 3 years.
Number of subjects: 884
Study 24947656 — intervention group
Group type: EXPERIMENTAL
Intervention: Women with initial mild dyskaryosis who were HrHPV-positive.
Number of subjects: 884
Study 24036618 — intervention group
Group type: EXPERIMENTAL
Intervention: Diabetic nephropathy (DN) patients
Number of subjects: 79
Study 24036618 — intervention group
Group type: EXPERIMENTAL
Intervention: CKD without diabetes
Number of subjects: 79
Study 24036618 — intervention group
Group type: COMPARATOR
Intervention: Controls
Number of subjects: 79
Study 21358291 — intervention group
Group type: EXPERIMENTAL
Intervention: Sanyinjiao (SP6) acupuncture
Number of subjects: 40
Study 21358291 — intervention group
Group type: COMPARATOR
Intervention: Xuanzhong (GB39) control group
Number of subjects: 40
Study 21358291 — intervention group
Group type: COMPARATOR
Intervention: Nonacupoint control group
Number of subjects: 40
Study 21358291 — intervention group
Group type: COMPARATOR
Intervention: No acupuncture group
Number of subjects: 40
Study 21358291 — intervention group
Group type: EXPERIMENTAL
Intervention: All acupuncture groups (SP6, GB39, nonacupoint)
Number of subjects: 40
Study 18972125 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin protection and skin care in combination
Number of subjects: 485
Study 18972125 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin care alone
Number of subjects: 485
Study 18972125 — intervention group
Group type: EXPERIMENTAL
Intervention: Skin protection alone
Number of subjects: 485
Study 18972125 — intervention group
Group type: COMPARATOR
Intervention: Control group (only cleansing)
Number of subjects: 485
Study 17060516 — intervention group
Group type: EXPERIMENTAL
Intervention: 2.0-g extended-release azithromycin microspheres (single-dose regimen)
Number of subjects: 24
Study 17060516 — intervention group
Group type: COMPARATOR
Intervention: 500-mg immediate-release azithromycin tablet (3-day regimen)
Number of subjects: 24
Study 14962523 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone 4 mg twice daily
Number of subjects: 108
Study 14962523 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 108
Study 14962523 — intervention group
Group type: EXPERIMENTAL
Intervention: rosiglitazone
Number of subjects: 108
Study 11684346 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic stroke patients
Number of subjects: 25
Study 11684346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients not taking aspirin
Number of subjects: 25
Study 11684346 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients taking aspirin
Number of subjects: 25
Study 9559631 — intervention group
Group type: COMPARATOR
Intervention: Neomycin and erythromycin (Group 1)
Number of subjects: 82
Study 9559631 — intervention group
Group type: EXPERIMENTAL
Intervention: Neomycin and metronidazole (Group 2)
Number of subjects: 82
Study 7929019 — intervention group
Group type: EXPERIMENTAL
Intervention: Bupropion
Number of subjects: 19
Study 7929019 — intervention group
Group type: COMPARATOR
Intervention: Desipramine
Number of subjects: 19
Study 2907898 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol I: 7 injections of 1,500 IU hCG every other day
Number of subjects: 183
Study 2907898 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol II: 4 injections of 100 IU/kg hCG at 4- to 5-day intervals
Number of subjects: 183
Study 31021691 — intervention group
Group type: EXPERIMENTAL
Intervention: Thoracic spine manipulation
Number of subjects: 43
Study 31021691 — intervention group
Group type: COMPARATOR
Intervention: Sham manipulation
Number of subjects: 43
Study 28360187 — intervention group
Group type: EXPERIMENTAL
Intervention: FGR children
Number of subjects: 96
Study 24748286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular PRP injections (3 injections at monthly intervals)
Number of subjects: 93
Study 24748286 — intervention group
Group type: EXPERIMENTAL
Intervention: Intra-articular PRP injections (2 cycles of 3 injections)
Number of subjects: 93
Study 23899048 — intervention group
Group type: EXPERIMENTAL
Intervention: Task-oriented training with trunk restraint
Number of subjects: 16
Study 23899048 — intervention group
Group type: COMPARATOR
Intervention: Task-oriented training without trunk restraint
Number of subjects: 16
Study 21576281 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise‐based lifestyle intervention (initial gym‐based program and lifestyle and diet advice followed by telephone‐guided supervision)
Number of subjects: 223
Study 21576281 — intervention group
Group type: COMPARATOR
Intervention: Usual care
Number of subjects: 223
Study 21576281 — intervention group
Group type: EXPERIMENTAL
Intervention: Supervised exercise‐based lifestyle intervention
Number of subjects: 223
Study 19619607 — intervention group
Group type: EXPERIMENTAL
Intervention: Active tDCS (anodal tDCS of the left DLPFC)
Number of subjects: 27
Study 19619607 — intervention group
Group type: COMPARATOR
Intervention: Sham tDCS
Number of subjects: 27
Study 16490513 — intervention group
Group type: EXPERIMENTAL
Intervention: Ibopamine 2% solution administered as eyedrops
Number of subjects: 10
Study 16490513 — intervention group
Group type: COMPARATOR
Intervention: Placebo eyedrop
Number of subjects: 10
Study 15016484 — intervention group
Group type: EXPERIMENTAL
Intervention: Cell infusion
Number of subjects: 27
Study 15016484 — intervention group
Group type: EXPERIMENTAL
Intervention: G-CSF alone
Number of subjects: 27
Study 15016484 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 27
Study 11735095 — intervention group
Group type: EXPERIMENTAL
Intervention: Fasting homocysteine (tHcy) levels
Number of subjects: 600
Study 11735095 — intervention group
Group type: EXPERIMENTAL
Intervention: Homocysteine levels 4 hours after methionine load
Number of subjects: 600
Study 11735095 — intervention group
Group type: EXPERIMENTAL
Intervention: Prevalence of hyperhomocysteinemia
Number of subjects: 600
Study 11735095 — intervention group
Group type: EXPERIMENTAL
Intervention: Association with concurrent diseases
Number of subjects: 600
Study 11735095 — intervention group
Group type: EXPERIMENTAL
Intervention: Multiple stepwise regression analysis
Number of subjects: 600
Study 9207407 — intervention group
Group type: EXPERIMENTAL
Intervention: Daunorubicin (DR)
Number of subjects: 1419
Study 9207407 — intervention group
Group type: COMPARATOR
Intervention: No Daunorubicin (no DR)
Number of subjects: 1419
Study 8188884 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium lauryl sulfate (SLS)
Number of subjects: 11
Study 8188884 — intervention group
Group type: EXPERIMENTAL
Intervention: Dodecyl trimethyl ammonium bromide (DTAB)
Number of subjects: 11
Study 8188884 — intervention group
Group type: COMPARATOR
Intervention: Potassium soap
Number of subjects: 11
Study 3311687 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimetidine (800 mg) and Pirenzepine (50 mg) at bed-time
Number of subjects: 129
Study 3311687 — intervention group
Group type: COMPARATOR
Intervention: Cimetidine (800 mg) and Placebo at bed-time
Number of subjects: 129
Study 29353535 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day fasting (ADF)
Number of subjects: 34
Study 27385430 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication organisation devices (MODs) supplied either weekly or monthly
Number of subjects: 147
Study 27385430 — intervention group
Group type: EXPERIMENTAL
Intervention: Medication organisation devices (MODs)
Number of subjects: 147
Study 27385430 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control)
Number of subjects: 147
Study 27385430 — intervention group
Group type: EXPERIMENTAL
Intervention: MOD monthly
Number of subjects: 147
Study 27385430 — intervention group
Group type: EXPERIMENTAL
Intervention: MODs
Number of subjects: 147
Study 24423928 — intervention group
Group type: EXPERIMENTAL
Intervention: Rapid genetic counselling and testing (RGCT)
Number of subjects: 265
Study 24423928 — intervention group
Group type: EXPERIMENTAL
Intervention: DNA test results before surgery (within RGCT group)
Number of subjects: 265
Study 24423928 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 265
Study 23532993 — intervention group
Group type: EXPERIMENTAL
Intervention: Behaviorally focused maintenance treatment (MT)
Number of subjects: 101
Study 23532993 — intervention group
Group type: COMPARATOR
Intervention: Socially focused maintenance treatment (MT)
Number of subjects: 101
Study 20093826 — intervention group
Group type: EXPERIMENTAL
Intervention: Citrate anticoagulation
Number of subjects: 0
Study 20093826 — intervention group
Group type: COMPARATOR
Intervention: Heparin anticoagulation
Number of subjects: 0
Study 19064606 — intervention group
Group type: EXPERIMENTAL
Intervention: Algorithm for diagnosis of active labour
Number of subjects: 4503
Study 19064606 — intervention group
Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 4503
Study 16914460 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX-0.2
Number of subjects: 54
Study 16914460 — intervention group
Group type: EXPERIMENTAL
Intervention: DEX-0.4
Number of subjects: 54
Study 16914460 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 54
Study 12835242 — intervention group
Group type: EXPERIMENTAL
Intervention: Caribbean origin
Number of subjects: 708
Study 12835242 — intervention group
Group type: COMPARATOR
Intervention: British White origin
Number of subjects: 708
Study 11168739 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20 mg 2x daily for 12 weeks
Number of subjects: 75
Study 11168739 — intervention group
Group type: EXPERIMENTAL
Intervention: Subantimicrobial dose doxycycline (SDD) 20 mg 1x daily in part III
Number of subjects: 75
Study 11168739 — intervention group
Group type: COMPARATOR
Intervention: Placebo capsules
Number of subjects: 75
Study 9760806 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele I of the ACE gene
Number of subjects: 128
Study 9760806 — intervention group
Group type: EXPERIMENTAL
Intervention: Allele D of the ACE gene
Number of subjects: 128
Study 9760806 — intervention group
Group type: COMPARATOR
Intervention: Normotensives and borderline to mild hypertensives
Number of subjects: 128
Study 8141188 — intervention group
Group type: EXPERIMENTAL
Intervention: Diethylstilbestrol exposure
Number of subjects: 198
Study 8141188 — intervention group
Group type: COMPARATOR
Intervention: Control (unexposed)
Number of subjects: 198
Study 2448190 — intervention group
Group type: EXPERIMENTAL
Intervention: Methotrexate (MTX)
Number of subjects: 21
Study 2448190 — intervention group
Group type: COMPARATOR
Intervention: Methotrexate (MTX) with citrovorum factor
Number of subjects: 21
Study 2448190 — intervention group
Group type: COMPARATOR
Intervention: Spontaneous decline post-evacuation
Number of subjects: 21
Study 31795755 — intervention group
Group type: EXPERIMENTAL
Intervention: Covariate presumed as random
Number of subjects: 0
Study 31795755 — intervention group
Group type: COMPARATOR
Intervention: Covariate presumed as fixed
Number of subjects: 0
Study 30026230 — intervention group
Group type: EXPERIMENTAL
Intervention: Arthroscopic subacromial decompression (ASD)
Number of subjects: 210
Study 30026230 — intervention group
Group type: COMPARATOR
Intervention: Diagnostic arthroscopy (placebo control)
Number of subjects: 210
Study 30026230 — intervention group
Group type: COMPARATOR
Intervention: Exercise therapy
Number of subjects: 210
Study 28499257 — intervention group
Group type: EXPERIMENTAL
Intervention: Standardised mindfulness technique
Number of subjects: 0
Study 28499257 — intervention group
Group type: COMPARATOR
Intervention: Mindfulness-based interventions
Number of subjects: 0
Study 26230671 — intervention group
Group type: EXPERIMENTAL
Intervention: 300 mg/day intranasal glutathione
Number of subjects: 30
Study 26230671 — intervention group
Group type: EXPERIMENTAL
Intervention: 600 mg/day intranasal glutathione
Number of subjects: 30
Study 26230671 — intervention group
Group type: COMPARATOR
Intervention: Placebo (saline)
Number of subjects: 30
Study 24124993 — intervention group
Group type: EXPERIMENTAL
Intervention: Modified constraint-induced movement therapy (CIMT at home)
Number of subjects: 144
Study 24124993 — intervention group
Group type: COMPARATOR
Intervention: Conventional physical and occupational therapy (therapy as usual)
Number of subjects: 144
Study 21923696 — intervention group
Group type: EXPERIMENTAL
Intervention: Sitagliptin 100 mg/day
Number of subjects: 20
Study 21923696 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 20
Study 18539527 — intervention group
Group type: EXPERIMENTAL
Intervention: Mobile phone-based Advanced Symptom Management System (ASyMS©)
Number of subjects: 35
Study 17157113 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir morning injection
Number of subjects: 504
Study 17157113 — intervention group
Group type: EXPERIMENTAL
Intervention: Insulin detemir evening injection
Number of subjects: 504
Study 17157113 — intervention group
Group type: COMPARATOR
Intervention: NPH evening injection
Number of subjects: 504
Study 14616819 — intervention group
Group type: EXPERIMENTAL
Intervention: UVA-1 irradiation (40 J/cm2)
Number of subjects: 28
Study 14616819 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 28
Study 10891736 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg with 2 g of amoxicillin and 1 g of clarithromycin for 10 days
Number of subjects: 665
Study 10891736 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg with 2 g of amoxicillin and 1 g of clarithromycin for 7 days
Number of subjects: 665
Study 10891736 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg with 2 g of amoxicillin and 1 g of clarithromycin for 10 days
Number of subjects: 665
Study 10891736 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 30 mg with 2 g of amoxicillin and 1 g of clarithromycin for 7 days
Number of subjects: 665
Study 10891736 — intervention group
Group type: EXPERIMENTAL
Intervention: Lansoprazole 60 mg
Number of subjects: 665
Study 8922877 — intervention group
Group type: EXPERIMENTAL
Intervention: ZK 136295 (60 micrograms i.v. and 120/240 micrograms oral)
Number of subjects: 54
Study 8922877 — intervention group
Group type: EXPERIMENTAL
Intervention: ZK 115194 (60 micrograms i.v. and 240 micrograms oral)
Number of subjects: 54
Study 8922877 — intervention group
Group type: COMPARATOR
Intervention: Ethinylestradiol (EE2) (60 micrograms i.v. and 120/240 micrograms oral)
Number of subjects: 54
Study 1348771 — intervention group
Group type: EXPERIMENTAL
Intervention: Handrub with 2 portions of 3 ml of 2-propanol 60% v/v for 1 min
Number of subjects: 16
Study 1348771 — intervention group
Group type: COMPARATOR
Intervention: Handwash with liquid soap 20% w/v for 1 min followed by a 15 s rinse
Number of subjects: 16
Study 29696420 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexamethasone (3 daily 8-mg doses starting 48 hours before bleaching)
Number of subjects: 70
Study 29696420 — intervention group
Group type: COMPARATOR
Intervention: Placebo (3 daily doses starting 48 hours before bleaching)
Number of subjects: 70
Study 29696420 — intervention group
Group type: COMPARATOR
Intervention: Dexamethasone and Placebo
Number of subjects: 70
Study 30150627 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent retraining group (FG)
Number of subjects: 104
Study 30150627 — intervention group
Group type: COMPARATOR
Intervention: Conventional retraining group (CG)
Number of subjects: 104
Study 30150627 — intervention group
Group type: EXPERIMENTAL
Intervention: Frequent retraining group (FG) in older subgroup (age ≥ 60)
Number of subjects: 104
Study 26673440 — intervention group
Group type: EXPERIMENTAL
Intervention: Guideline-oriented medical treatment
Number of subjects: 111
Study 26673440 — intervention group
Group type: COMPARATOR
Intervention: Surgical treatment (carotid endarterectomy or carotid artery stenting)
Number of subjects: 111
Study 24850625 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation (10 mg/d of zinc sulfate, 10 mg/d of iron, and 0.5 mg/d of copper)
Number of subjects: 0
Study 24850625 — intervention group
Group type: COMPARATOR
Intervention: Control group (10 mg/d of iron and 0.5 mg/d of copper)
Number of subjects: 0
Study 24850625 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc supplementation
Number of subjects: 0
Study 22104346 — intervention group
Group type: EXPERIMENTAL
Intervention: WB knee extension
Number of subjects: 30
Study 22104346 — intervention group
Group type: EXPERIMENTAL
Intervention: NWB knee extension
Number of subjects: 30
Study 22104346 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 30
Study 21961763 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Therapy for Command Hallucinations + Treatment as Usual
Number of subjects: 0
Study 21961763 — intervention group
Group type: COMPARATOR
Intervention: Treatment as Usual
Number of subjects: 0
Study 17688659 — intervention group
Group type: EXPERIMENTAL
Intervention: Tegaserod 6 mg twice daily for 12 weeks
Number of subjects: 44
Study 16214626 — intervention group
Group type: EXPERIMENTAL
Intervention: Extraction patients
Number of subjects: 40
Study 16214626 — intervention group
Group type: COMPARATOR
Intervention: Nonextraction patients
Number of subjects: 40
Study 16214626 — intervention group
Group type: EXPERIMENTAL
Intervention: Males
Number of subjects: 40
Study 16214626 — intervention group
Group type: EXPERIMENTAL
Intervention: Females
Number of subjects: 40